Suprachoroidal Triamcinolone Acetonide Injection in Two Chorioretinal Diseases: One Year Results
Status: Unknown
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY
Suprachoroidal injection is a safe way for intraocular drug delivery. It was used to treat various retinal conditions.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Maximum Age: 70
Healthy Volunteers: f
View:
• patients diagnosed as central serous chorioretinopathy and patients with cystoid macular edema due to irvine-gass syndrome after cataract surgery.
Locations
Other Locations
Egypt
Ahmed Abdelshafy
RECRUITING
Banhā
Contact Information
Primary
Ahmed Abdelshafy, MD
ahmad4lg@gmail.com
01222328766
Backup
Marwa Abdelshafy, MD
ahmad4lg@gmail.com
01222328766
Time Frame
Start Date: 2022-04-14
Completion Date: 2023-06-01
Participants
Target number of participants: 50
Treatments
Experimental: Central serous chorioretinopathy group
Cases with central serous chorioretinopathy (CSR) that will be injected with suprachoroidal triamcinolone acetonide.
Experimental: Irvine-Gass Syndrome group
Cases with cystoid macular edema due to irvine-gass syndrome that will be injected with suprachoroidal triamcinolone acetonide
Related Therapeutic Areas
Sponsors
Leads: Benha University